Amneal Pharmaceuticals (AMRX) Work In Process (2017 - 2020)

Amneal Pharmaceuticals' Work In Process history runs 4 years deep, the most recent figure standing at $53.1 million for Q1 2020.

• In Q1 2020, Work In Process changed N/A year-over-year to $53.1 million; the TTM figure through Mar 2020 stood at $53.1 million (changed N/A YoY), while the FY2019 annual figure was $58.2 million, up 7.45% from the prior year.
• Work In Process was $53.1 million for Q1 2020 at Amneal Pharmaceuticals, down from $58.2 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $59.2 million in Q2 2018 to a low of $38.1 million in Q4 2017.
• Historically, Work In Process has averaged $50.4 million across 4 years, with a median of $52.1 million in 2018.
• The sharpest annual moves came in 2018 and 2019: Work In Process soared 41.96% in 2018, then plunged 35.13% in 2019.
• A 4-year view of Work In Process shows it stood at $38.1 million in 2017, then jumped by 41.96% to $54.2 million in 2018, then increased by 7.45% to $58.2 million in 2019, then decreased by 8.79% to $53.1 million in 2020.
• The last three Work In Process figures came in at $53.1 million (Q1 2020), $58.2 million (Q4 2019), and $50.8 million (Q3 2019), per Business Quant data.